Rigel Pharmaceuticals Inc (NASDAQ:RIGL)
| 1.08 Delayed Data As of Sep 22 |  -0.04 / -3.57%Today’s Change | 0.67 Today|||52-Week Range 2.04 | -28.00% Year-to-Date |
Latest RIGL News | Press Releases
No recent news for Rigel Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.12 |
| Today’s open | 1.12 |
| Day’s range | 1.04 - 1.12 |
| Volume | 40,241 |
| Average volume (3 months) | 1,708,635 |
| Market cap | $185.7M |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -223.22% |
| Earnings growth (this year) | +18.22% |
| Earnings growth (next 5 years) | +42.00% |
| Revenue growth (last year) | -19.43% |
| P/E ratio | NM |
| Price/Sales | 2.15 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STOKStoke Therapeutics I... | +0.03 | +0.72% |
| MREOMereo Biopharma Grou... | +0.04 | +3.01% |
| DNTHDianthus Therapeutic... | +0.23 | +1.75% |
| XOMAXOMA Corp | -0.34 | -2.16% |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $120.2M |
| Annual profit (last year) | -$58.6M |
| Net profit margin | -48.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
